Plato Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,816
Closed -$191K 616
2024
Q4
$191K Buy
4,816
+3,912
+433% +$148K 0.01% 412
2024
Q3
$30.7K Hold
904
﹤0.01% 464
2024
Q2
$19.6K Hold
904
﹤0.01% 430
2024
Q1
$20K Buy
904
+700
+343% +$17.1K ﹤0.01% 412
2023
Q4
$5.61K Buy
+204
New +$4.92K 0.01% 380

Other funds holding VCYT

Plato Investment Management's VCYT Position: Q1 2025 in Review

Plato Investment Management sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 4,816 shares — an estimated $191K sold.

Plato Investment Management first reported a position in VCYT in Q4 2023 and held it in 5 quarters. The position peaked at $191K in Q4 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Plato Investment Management reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • Plato Investment Management sold 4,816 Veracyte shares in Q1 2025, an estimated $191K.
  • Plato Investment Management first reported a position in Veracyte in Q4 2023 and held it in 5 quarters.
  • Plato Investment Management's Veracyte position peaked at $191K in Q4 2024.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Plato Investment Management's 13F filing for Q1 2025, filed 20 May 2025.